Limba
Romanian
Romanian
English|
Ralimetinib (LY2228820) dimesylate, 50mg
6.475,98 RON
SKU
SKM_S1494_50mg
Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPKwith IC50of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.
| Price | 5.442,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPKwith IC50of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2. |
